• Home
  • NEW DAY MEDICINE
  • 9 (47) 2022
  • 70 — 9 (47) 2022 — Ismatova M.N., Umurova N.M., Allamuradova F.Y., CLINICAL AND LABORATORY CHARACTERISTICS OF HEMOSTASIS IN PATIENTS WITH METABOLIC SYNDROME

70 — 9 (47) 2022 — Ismatova M.N., Umurova N.M., Allamuradova F.Y., CLINICAL AND LABORATORY CHARACTERISTICS OF HEMOSTASIS IN PATIENTS WITH METABOLIC SYNDROME

CLINICAL AND LABORATORY CHARACTERISTICS OF HEMOSTASIS IN PATIENTS WITH METABOLIC SYNDROME

Ismatova M.N., Bukhara State Medical Institute

Umurova N.M., Bukhara State Medical Institute

Resume

Metabolic syndrome-is one of the most important problems of medicine. This is due, firstly, to the fact that this syndrome occurs in 25-35% of the world’s population, and secondly, the risk of death from cardiovascular disease in patients with this syndrome is 2-3 times higher than in patients without metabolic syndrome, type 2 The risk of developing diabetes is 5-9 times higher. The research was conducted at the Medical Association of Kagan, Bukhara region of the Republic of Uzbekistan, a comparative study of clinical signs and laboratory parameters of patients with metabolic syndrome.

Keywords: Metabolic syndrome, hemostasis condition, dyslipidemia

First page

420

Last page

423

For citation: Ismatova M.N., Umurova N.M., Allamuradova F.Y., CLINICAL AND LABORATORY CHARACTERISTICS OF HEMOSTASIS IN PATIENTS WITH METABOLIC SYNDROME //New Day in Medicine 9 (47)2022 420-423 https://l.clck.bar/0370c

LIST OF REFERENCES:

  1. Ismatova M.N., Sushinsky V.E., Nuritdinov Sh.F., Kalandarova U.A. Some indicators of the platelet hemostasis in individuals with different attitudes to their health. Евразийский вестник педиатрии 2020№3 vol 1-c 36-40
  2. Ismatova M.N., Shadjanova N.S. The state of thrombocytic link of gemostasis in case of insulin resistance syndrome. // ACADEMICIA An internasional Multidisciplinary Research Journal. Vol 10.Issue 5 May 2020. P. 1795-1798.
  3. Mukhamedjanova M.Kh., Safarova GA Development of anemia in patients with chronic hepatitis C on the background of combined antiviral therapy. Asian journal of Pharmaceutical and biological research 2231-2218. http://www.ajpbr.org/ Universal IMPACT factor 7 Volume 11 Issue 1 JAN-APR 2022 P. 69-73. https://doi.org/10.5281/zenodo.6471634
  4. Mukhamedjanova M.Kh., Safarova G.A. Evaluation of vasorenal hemodynamics in patients with chronic kidney disease in association with arterial hypertension // Problems of biology and medicine 2020, no. 6 (124) P. 87-90. UDC: 616.1+615.2.03+613.1
  5. Mukhamedjanova M.H. Anemia in patients with interference and interpretation of modern therapy. NDM 4(36)2021 P. 150-152
  6. Sean Campbell, in Contemporary Practice in Clinical Chemistry (Fourth Edition), 2020
  7. Макацария А.Д., Передеряева Е.Б., Пшеничникова Т.Б. Метаболический синдром и низкомолекулярные гепарины // Consilium medicum. – 2006. – № 6. – С. 35-41.
  8. Александров О.В., Алехина Р.М., Григорьев С.П., Ежова И.С., Золкина И.В. Метаболический синдром // Российский медицинский журнал. – 2006. – №6. – С. 50-55.
  9. Бутрова С.А. От эпидемии ожирения к эпидемии сахарного диабета // Consilium medicum. – 2003. – № 9. – С. 524-528
  10. Мамедов М.Н., Оганов Р.Г. Эпидемиологические аспекты метаболического синдрома // Кардиология. – 2004. – № 9. – С. 4-8
  11. Зиновкина В.Ю., Висмонт Ф.И., Касап В.А. З – 63 Нарушения гемостаза: Метод. реком. – Мн.: МГМИ, 2000.
  12. Kayumov U.K.1, Ismatova M.N.2, Ziyamukhamedova M.V.1, Saipova M.L.1, Assessment of the correlation of the prothrombin index with the main indicators of glycemia // New Day in Medicine 3(31)2020 552-555 (14.00.00, №22). https://cutt.ly/WxGuigw

file

download